Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,933 | -14,845 | 1,166 | N/A | -65,973 |
| Depreciation Amortization | 1,139 | 753 | 320 | N/A | 1,426 |
| Other Working Capital | 3,174 | -2,552 | 181 | N/A | 45,622 |
| Other Operating Activity | -21,772 | -19,075 | -20,108 | 0 | -39,448 |
| Operating Cash Flow | $-44,392 | $-35,719 | $-18,441 | $N/A | $-58,373 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -592 | -586 | -392 | N/A | -3,117 |
| Net Acquisitions | 24,203 | 24,203 | 24,203 | N/A | N/A |
| Investing Cash Flow | $23,611 | $23,617 | $23,811 | $N/A | $-3,117 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 27,328 |
| Common Stock Repurchased | 32 | 32 | N/A | N/A | 107 |
| Financing Cash Flow | $32 | $32 | $N/A | $N/A | $27,435 |
| Exchange Rate Effect | 1,292 | 1,958 | 1,136 | N/A | -17,949 |
| Beginning Cash Position | 48,909 | 48,909 | 48,909 | N/A | 119,063 |
| End Cash Position | 29,452 | 38,797 | 55,415 | N/A | 67,059 |
| Net Cash Flow | $-19,457 | $-10,112 | $6,506 | $N/A | $-52,004 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,392 | -35,719 | -18,441 | N/A | -58,373 |
| Capital Expenditure | -654 | -648 | -392 | N/A | -3,117 |
| Free Cash Flow | -45,046 | -36,367 | -18,833 | 0 | -61,490 |